Francesco Marampon

6PUBLICATIONS
15CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Radiation therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Nov 03, 2025
Neddylation inhibition induces DNA double-strand breaks, hampering tumor growth in vivo, and promotes radiosensitivity in PAX3-FOXO1 rhabdomyosarcoma.

Francesca Antonella Aiello, Lucrezia D'Archivio, Marika Attili

|Aug 14, 2025
The HIV Protease Inhibitor Ritonavir Reverts the Mesenchymal Phenotype Induced by Inflammatory Cytokines in Normal and Tumor Oral Keratinocytes to an Epithelial One, Increasing the Radiosensitivity of Tumor Oral Keratinocytes.

Silvia Pomella, Lucrezia D'Archivio, Matteo Cassandri

|Aug 06, 2024
HDAC3 genetic and pharmacologic inhibition radiosensitizes fusion positive rhabdomyosarcoma by promoting DNA double-strand breaks.

Matteo Cassandri, Antonella Porrazzo, Silvia Pomella

|Feb 01, 2019
NRF2 orchestrates the redox regulation induced by radiation therapy, sustaining embryonal and alveolar rhabdomyosarcoma cells radioresistance.

Francesco Marampon, Silvia Codenotti, Francesca Megiorni

|Jul 01, 2018
Disruption of MEK/ERK/c-Myc signaling radiosensitizes prostate cancer cells in vitro and in vivo.

Carmela Ciccarelli, Agnese Di Rocco, Giovanni Luca Gravina

|Oct 08, 2017
Pharmacological targeting of the ephrin receptor kinase signalling by GLPG1790 in vitro and in vivo reverts oncophenotype, induces myogenic differentiation and radiosensitizes embryonal rhabdomyosarcoma cells.

Francesca Megiorni, Giovanni Luca Gravina, Simona Camero

Pageof 1

Frequent Collaborators

3 joint publications

Rossella Rota

2 joint publications

Matteo Cassandri

2 joint publications

Franco Locatelli

1 joint publications

Clemens Zwergel